Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 July 2023 | Story Valentino Ndaba
GEAD Infographic

The Gender Equality and Anti-Discrimination Office (GEADO) is an integral part of the University of the Free State’s (UFS) Unit for Institutional Change and Social Justice. Its primary focus is to create a safe and inclusive environment for students and staff. The office plays a crucial role in shaping the student experience and in fostering inclusivity in student accommodation and residence environments.

The GEADO takes proactive steps to achieve this, including implementing guidelines and policies to address and prevent gender-based violence and sexual misconduct. It also conducts conscientisation workshops to raise awareness, challenge biases, and promote empathy among stakeholders.

“As an integral component of our initiatives, the GEADO implements proactive measures to foster safe spaces for students, through the establishment of its Sexual Offence Response Team (SORT) and sexual harassment guidelines,” said Dr Lentsu Nchabeleng, Deputy Director of the Gender Equality and Anti-Discrimination Office. She further emphasised, “These frameworks are formulated to tackle and prevent occurrences of gender-based violence and sexual misconduct, ensuring a secure, healthy, and conducive environment for both students and staff to flourish and develop as individuals and as a community.” The GEADO is currently reviewing the UFS Sexual Harassment, Sexual Misconduct, and Sexual Violence Policy to strengthen its commitment to a zero-tolerance stance on gender-based violence and sexual misconduct.

Beyond addressing specific incidents, the GEADO aims to cultivate an inclusive and socially just atmosphere across the UFS’s campuses. It closely monitors the environment, identifies trends, and stays updated on global and local interventions to positively impact its work.

The office is a driving force behind fostering a safe, inclusive, and socially just campus culture that embraces gender equality and combats discrimination. It partners with LGBTIAQ+ (lesbian, gay, bisexual, transgender, intersex, asexual, queer, and others) organisations like Free State Rainbow Seeds to further support its mission. Some of the programmes championed by the office include safety zone training, sexuality sensitisation, and diversity training.

Safe zone training

The Safe Zones@UFS project is modelled after a similar programme in the USA, specifically the Safe Zones Project at San Diego State University. Its purpose is to create a supportive and safe environment for individuals who identify as LGBTIAQ+.

Dr Nchabeleng said the project encompasses the training of faculty members and students to become Safe Zones allies, offering support to students, staff, as well as families and friends of individuals identifying as LGBTIAQ+. She emphasised that the role of Safe Zone allies involves providing assistance to LGBTIAQ+ students and staff during their coming-out process, serving as an informative resource for LGBTIAQ+ matters, advocating for LGBTIAQ+ rights, and acting as a referral point for other essential services, including medical and counselling support.

Sexuality sensitisation

Gender and sexuality sensitisation is crucial for fostering inclusive and respectful environments in educational institutions, workplaces, and communities. It involves raising awareness about consent, sexual minorities, and diverse gender identities, while addressing gender-based violence, sexual harassment, and misconduct. The approach includes consent education, understanding sexual minorities, exploring gender identities, combating gender-based violence and harassment, promoting safe spaces, challenging stereotypes, encouraging allyship, and promoting positive masculinity and femininity. Overall, these efforts create a more understanding and supportive community in which individuals of all genders and sexual orientations can thrive.

Diversity Training

The Diversity Training programme focuses on increasing awareness and understanding of diverse backgrounds and experiences. It includes workshops and training to address unconscious bias, promoting a fair and equitable environment. The goal is to create a sense of belonging, where everyone feels accepted and valued. The programme is flexible and can be customised for organisations or communities, and it can be delivered through various formats. Embracing diversity and inclusion can lead to better outcomes, improved teamwork, and the attracting of diverse talent. Overall, it fosters a culture of inclusivity and appreciation for diverse perspectives, benefitting both individuals and organisations.

Important contact information

Bloemfontein Campus: +27 51 401 3982

South Campus: +27 51 401 7544

Qwaqwa Campus: +27 58 718 5431

Toll-free number +27 80 020 4682

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept